Tanaya A. Purohit

University of Wisconsin System

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

University of Wisconsin System

Research Subjects

Research Interests

Tanaya A. Purohit has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

David F. Jarrard
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
15 shared publications
Abbas Jawadwala
University at Buffalo 1 Division of Hematology and Oncology, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences Buffalo, New York
14 shared publications
Adam G. Sowalsky
Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA
14 shared publications
Bing Yang
University of Wisconsin School of Medicine and Public Health 4 , Madison, Wisconsin
14 shared publications
Brian Capaldo
National Cancer Institute 6 Center for Biomedical Informatics & Information Technology Bethesda, Maryland
14 shared publications
Chao Xue
Proteomics & Bioanalysis Lab, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo (M.M., C.X., M.Z., J.Q.).
14 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM Overexpression CRPC are vulnerable to PARP inhibitors and inhibitors of the DNA repair pathway irrespective of HRR or DDR genes mutation status
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM Overexpression CRPC are vulnerable to PARP inhibitors and inhibitors of the DNA repair pathway irrespective of HRR or DDR genes mutation status
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM suppression enhances spheroid inhibition and apoptosis
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM suppression enhances spheroid inhibition and apoptosis
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Ranking of Differential Expressed Transcription Factors Related to Figure 1C
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Ranking of Differential Expressed Transcription Factors Related to Figure 1C
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
PARP inhibitors in combination with enzalutamide suppress MECOM and AR expression, suppress proliferation, and increase apoptosis in enzalutamide-resistant CRPC
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S7 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
PARP inhibitors in combination with enzalutamide suppress MECOM and AR expression, suppress proliferation, and increase apoptosis in enzalutamide-resistant CRPC
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM overexpression is associated with treatment resistance
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
MECOM overexpression is associated with treatment resistance
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Functional suppression of MECOM alters AR binding and H3K27ac enrichment in CRPC cell lines
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Functional suppression of MECOM alters AR binding and H3K27ac enrichment in CRPC cell lines
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Transcription Factor (TFs) and Frequecncy of TF top-enriched GREAT generated TF-target gene sets
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S3 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Transcription Factor (TFs) and Frequecncy of TF top-enriched GREAT generated TF-target gene sets
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Pathways enriched by SE-driven genes
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S6 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
Pathways enriched by SE-driven genes
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
AR_Unique Sites following expsoure to Enzalutamide in Enzalutamide-Resistant CRPC
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
by Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, et al.
AR_Unique Sites following expsoure to Enzalutamide in Enzalutamide-Resistant CRPC

Show all